United Biotech Daunorubicin Hydrochloride Injection

Daunorubicin Hydrochloride Injection is a potent chemotherapy medication used in the treatment of certain types of cancer. It belongs to the class of drugs known as anthracyclines, which are highly effective in combating various malignancies. The injection contains Daunorubicin Hydrochloride as the active ingredient and is formulated to slow down or inhibit the growth and spread of cancer cells in the body.
Indications:
Daunorubicin Hydrochloride Injection is primarily indicated for the treatment of various types of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and certain forms of chronic myeloid leukemia (CML). It is also used in the treatment of other types of cancer, such as certain types of lymphoma and solid tumors, depending on the specific treatment protocols.
Mode of Action:
Daunorubicin Hydrochloride works by interfering with the DNA and RNA synthesis in cancer cells. It exerts its cytotoxic effects by inhibiting the action of an enzyme called topoisomerase II, which is essential for DNA replication and repair. By disrupting these processes, the drug hinders the cancer cells' ability to proliferate and survive, leading to their death.